-   directed: true
    graph:
        disease: Tear film insufficiency
        disease_mesh: MESH:D015352
        drug: ciclosporin
        drug_mesh: MESH:D016572
        drugbank: DB:DB00091
    links:
    -   key: decreases activity of
        source: MESH:D016572
        target: UniProt:P62937
    -   key: participates in
        source: UniProt:P62937
        target: GO:0005955
    -   key: positively regulates
        source: GO:0005955
        target: GO:0070884
    -   key: positively regulates
        source: GO:0005955
        target: GO:0070884
    -   key: positively regulates
        source: GO:0070884
        target: GO:0032623
    -   key: positively regulates
        source: GO:0032623
        target: GO:0042098
    -   key: positively regulates
        source: GO:0032623
        target: GO:0042110
    -   key: positively correlated with
        source: GO:0042098
        target: GO:0006954
    -   key: positively correlated with
        source: GO:0042110
        target: GO:0006954
    -   key: positively correlated with
        source: GO:0006954
        target: MESH:D015352
    multigraph: true
    nodes:
    -   id: MESH:D016572
        label: Drug
        name: ciclosporin
    -   id: UniProt:P62937
        label: Protein
        name: Peptidyl-prolyl cis-trans isomerase A
    -   id: GO:0005955
        label: CellularComponent
        name: Calcineurin complex
    -   id: GO:0070884
        label: BiologicalProcess
        name: calcineurin-NFAT signaling cascade
    -   id: GO:0032623
        label: BiologicalProcess
        name: Interleukin-2 production
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: GO:0042098
        label: BiologicalProcess
        name: T cell proliferation
    -   id: GO:0042110
        label: BiologicalProcess
        name: T cell activation
    -   id: MESH:D015352
        label: Disease
        name: Tear film insufficiency
    reference:
    - https://go.drugbank.com/drugs/DB00091
    - https://en.wikipedia.org/wiki/Ciclosporin
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL160/
-   directed: true
    graph:
        disease: Keratoconjunctivitis sicca
        disease_mesh: MESH:D007638
        drug: ciclosporin
        drug_mesh: MESH:D016572
        drugbank: DB:DB00091
    links:
    -   key: decreases activity of
        source: MESH:D016572
        target: UniProt:P62937
    -   key: participates in
        source: UniProt:P62937
        target: GO:0005955
    -   key: positively regulates
        source: GO:0005955
        target: GO:0070884
    -   key: positively regulates
        source: GO:0005955
        target: GO:0070884
    -   key: positively regulates
        source: GO:0070884
        target: GO:0032623
    -   key: positively regulates
        source: GO:0032623
        target: GO:0042098
    -   key: positively regulates
        source: GO:0032623
        target: GO:0042110
    -   key: positively correlated with
        source: GO:0042098
        target: GO:0006954
    -   key: positively correlated with
        source: GO:0042110
        target: GO:0006954
    -   key: positively correlated with
        source: GO:0006954
        target: MESH:D007638
    multigraph: true
    nodes:
    -   id: MESH:D016572
        label: Drug
        name: ciclosporin
    -   id: UniProt:P62937
        label: Protein
        name: Peptidyl-prolyl cis-trans isomerase A
    -   id: GO:0005955
        label: CellularComponent
        name: Calcineurin complex
    -   id: GO:0070884
        label: BiologicalProcess
        name: calcineurin-NFAT signaling cascade
    -   id: GO:0032623
        label: BiologicalProcess
        name: Interleukin-2 production
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: GO:0042098
        label: BiologicalProcess
        name: T cell proliferation
    -   id: GO:0042110
        label: BiologicalProcess
        name: T cell activation
    -   id: MESH:D007638
        label: Disease
        name: Keratoconjunctivitis sicca
    reference:
    - https://go.drugbank.com/drugs/DB00091
    - https://en.wikipedia.org/wiki/Ciclosporin
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL160/
-   directed: true
    graph:
        disease: Rheumatoid arthritis
        disease_mesh: MESH:D001172
        drug: ciclosporin
        drug_mesh: MESH:D016572
        drugbank: DB:DB00091
    links:
    -   key: decreases activity of
        source: MESH:D016572
        target: UniProt:P62937
    -   key: participates in
        source: UniProt:P62937
        target: GO:0005955
    -   key: positively regulates
        source: GO:0005955
        target: GO:0070884
    -   key: positively regulates
        source: GO:0005955
        target: GO:0070884
    -   key: positively regulates
        source: GO:0070884
        target: GO:0032623
    -   key: positively regulates
        source: GO:0032623
        target: GO:0042098
    -   key: positively regulates
        source: GO:0032623
        target: GO:0042110
    -   key: positively correlated with
        source: GO:0042098
        target: GO:0006954
    -   key: positively correlated with
        source: GO:0042110
        target: GO:0006954
    -   key: positively correlated with
        source: GO:0006954
        target: MESH:D001172
    multigraph: true
    nodes:
    -   id: MESH:D016572
        label: Drug
        name: ciclosporin
    -   id: UniProt:P62937
        label: Protein
        name: Peptidyl-prolyl cis-trans isomerase A
    -   id: GO:0005955
        label: CellularComponent
        name: Calcineurin complex
    -   id: GO:0070884
        label: BiologicalProcess
        name: calcineurin-NFAT signaling cascade
    -   id: GO:0032623
        label: BiologicalProcess
        name: Interleukin-2 production
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: GO:0042098
        label: BiologicalProcess
        name: T cell proliferation
    -   id: GO:0042110
        label: BiologicalProcess
        name: T cell activation
    -   id: MESH:D001172
        label: Disease
        name: Rheumatoid arthritis
    reference:
    - https://go.drugbank.com/drugs/DB00091
    - https://en.wikipedia.org/wiki/Ciclosporin
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL160/
-   directed: true
    graph:
        disease: Depressive disorder
        disease_mesh: MESH:D003866
        drug: protriptyline
        drug_mesh: MESH:D011530
        drugbank: DB:DB00344
    links:
    -   key: decreases activity of
        source: MESH:D011530
        target: UniProt:P31645
    -   key: decreases activity of
        source: MESH:D011530
        target: UniProt:P23975
    -   key: participates in
        source: UniProt:P31645
        target: GO:0051610
    -   key: participates in
        source: UniProt:P23975
        target: GO:0051620
    -   key: decreases abundance of
        source: GO:0051620
        target: MESH:D009638
    -   key: decreases abundance of
        source: GO:0051610
        target: MESH:D012701
    -   key: positively correlated with
        source: MESH:D012701
        target: GO:0060096
    -   key: positively correlated with
        source: MESH:D009638
        target: GO:0061533
    -   key: negatively regulates
        source: GO:0060096
        target: MESH:D003866
    -   key: negatively regulates
        source: GO:0061533
        target: MESH:D003866
    multigraph: true
    nodes:
    -   id: MESH:D011530
        label: Drug
        name: protriptyline
    -   id: UniProt:P31645
        label: Protein
        name: Sodium-dependent serotonin transporter
    -   id: UniProt:P23975
        label: Protein
        name: Sodium-dependent noradrenaline transporter
    -   id: GO:0051610
        label: BiologicalProcess
        name: Serotonin uptake
    -   id: MESH:D012701
        label: ChemicalSubstance
        name: Serotonin
    -   id: GO:0051620
        label: BiologicalProcess
        name: Noradrenaline uptake
    -   id: MESH:D009638
        label: ChemicalSubstance
        name: Noradrenaline
    -   id: GO:0061533
        label: BiologicalProcess
        name: Norepinephrine secretion, neurotransmission
    -   id: GO:0060096
        label: BiologicalProcess
        name: Serotonin secretion, neurotransmission
    -   id: MESH:D003866
        label: Disease
        name: Depressive disorder
    reference:
    - https://go.drugbank.com/drugs/DB00344
    - https://en.wikipedia.org/wiki/Protriptyline
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL668/
-   comment: Primidone MoA is unknown. Its major metabolite are, phenobarbital and Phenylethylmalonamide,
             which are likely contributes to primidone's effects in many forms of epilepsy.
    directed: true
    graph:
        disease: Simple partial seizure
        disease_mesh: MESH:D004828
        drug: primidone
        drug_mesh: MESH:D011324
        drugbank: DB:DB00794
    links:
    -   key: has metabolite
        source: MESH:D011324
        target: CHEBI:8069
    -   key: has metabolite
        source: MESH:D011324
        target: CHEBI:8097
    -   key: increases activity of
        source: CHEBI:8069
        target: InterPro:IPR006028
    -   key: increases activity of
        source: CHEBI:8097
        target: InterPro:IPR006028
    -   key: positively regulates
        source: InterPro:IPR006028
        target: GO:0022851
    -   key: participates in
        source: InterPro:IPR006028
        target: GO:0022851
    -   key: positively correlated with
        source: GO:0022851
        target: GO:0060081
    -   key: negatively regulates
        source: GO:0060081
        target: GO:0019228
    -   key: contributes to
        source: GO:0019228
        target: GO:0050806
    -   key: positively correlated with
        source: GO:0050806
        target: MESH:D004828
    multigraph: true
    nodes:
    -   id: MESH:D011324
        label: Drug
        name: primidone
    -   id: CHEBI:8069
        label: ChemicalSubstance
        name: phenobarbital
    -   id: CHEBI:8097
        label: ChemicalSubstance
        name: Phenylethylmalonamide
    -   id: InterPro:IPR006028
        label: GeneFamily
        name: Gamma-aminobutyric acid A receptor/Glycine receptor alpha
    -   id: GO:0022851
        label: MolecularActivity
        name: GABA-gated chloride ion channel activity
    -   id: GO:0060081
        label: BiologicalProcess
        name: membrane hyperpolarization
    -   id: GO:0019228
        label: BiologicalProcess
        name: neuronal action potential
    -   id: GO:0050806
        label: BiologicalProcess
        name: positive regulation of synaptic transmission
    -   id: MESH:D004828
        label: Disease
        name: Simple partial seizure
    reference:
    - https://go.drugbank.com/drugs/DB00794
    - https://en.wikipedia.org/wiki/Primidone#Mechanism_of_action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL856/
-   comment: Primidone MoA is unknown. Its major metabolite are, phenobarbital and Phenylethylmalonamide,
             which are likely contributes to primidone's effects in many forms of epilepsy.
    directed: true
    graph:
        disease: Epilepsy
        disease_mesh: MESH:D004827
        drug: primidone
        drug_mesh: MESH:D011324
        drugbank: DB:DB00794
    links:
    -   key: has metabolite
        source: MESH:D011324
        target: CHEBI:8069
    -   key: has metabolite
        source: MESH:D011324
        target: CHEBI:8097
    -   key: increases activity of
        source: CHEBI:8069
        target: InterPro:IPR006028
    -   key: increases activity of
        source: CHEBI:8097
        target: InterPro:IPR006028
    -   key: positively regulates
        source: InterPro:IPR006028
        target: GO:0022851
    -   key: participates in
        source: InterPro:IPR006028
        target: GO:0022851
    -   key: positively correlated with
        source: GO:0022851
        target: GO:0060081
    -   key: negatively regulates
        source: GO:0060081
        target: GO:0019228
    -   key: contributes to
        source: GO:0019228
        target: GO:0050806
    -   key: positively correlated with
        source: GO:0050806
        target: MESH:D004827
    multigraph: true
    nodes:
    -   id: MESH:D011324
        label: Drug
        name: primidone
    -   id: CHEBI:8069
        label: ChemicalSubstance
        name: phenobarbital
    -   id: CHEBI:8097
        label: ChemicalSubstance
        name: Phenylethylmalonamide
    -   id: InterPro:IPR006028
        label: GeneFamily
        name: Gamma-aminobutyric acid A receptor/Glycine receptor alpha
    -   id: GO:0022851
        label: MolecularActivity
        name: GABA-gated chloride ion channel activity
    -   id: GO:0060081
        label: BiologicalProcess
        name: membrane hyperpolarization
    -   id: GO:0019228
        label: BiologicalProcess
        name: neuronal action potential
    -   id: GO:0050806
        label: BiologicalProcess
        name: positive regulation of synaptic transmission
    -   id: MESH:D004827
        label: Disease
        name: Epilepsy
    reference:
    - https://go.drugbank.com/drugs/DB00794
    - https://en.wikipedia.org/wiki/Primidone#Mechanism_of_action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL856/
-   comment: Primidone MoA is unknown. Its major metabolite are, phenobarbital and Phenylethylmalonamide,
             which are likely contributes to primidone's effects in many forms of epilepsy.
    directed: true
    graph:
        disease: Tonic-clonic seizure
        disease_mesh: MESH:D012640
        drug: primidone
        drug_mesh: MESH:D011324
        drugbank: DB:DB00794
    links:
    -   key: has metabolite
        source: MESH:D011324
        target: CHEBI:8069
    -   key: has metabolite
        source: MESH:D011324
        target: CHEBI:8097
    -   key: increases activity of
        source: CHEBI:8069
        target: InterPro:IPR006028
    -   key: increases activity of
        source: CHEBI:8097
        target: InterPro:IPR006028
    -   key: positively regulates
        source: InterPro:IPR006028
        target: GO:0022851
    -   key: participates in
        source: InterPro:IPR006028
        target: GO:0022851
    -   key: positively correlated with
        source: GO:0022851
        target: GO:0060081
    -   key: negatively regulates
        source: GO:0060081
        target: GO:0019228
    -   key: contributes to
        source: GO:0019228
        target: GO:0050806
    -   key: positively correlated with
        source: GO:0050806
        target: MESH:D012640
    multigraph: true
    nodes:
    -   id: MESH:D011324
        label: Drug
        name: primidone
    -   id: CHEBI:8069
        label: ChemicalSubstance
        name: phenobarbital
    -   id: CHEBI:8097
        label: ChemicalSubstance
        name: Phenylethylmalonamide
    -   id: InterPro:IPR006028
        label: GeneFamily
        name: Gamma-aminobutyric acid A receptor/Glycine receptor alpha
    -   id: GO:0022851
        label: MolecularActivity
        name: GABA-gated chloride ion channel activity
    -   id: GO:0060081
        label: BiologicalProcess
        name: membrane hyperpolarization
    -   id: GO:0019228
        label: BiologicalProcess
        name: neuronal action potential
    -   id: GO:0050806
        label: BiologicalProcess
        name: positive regulation of synaptic transmission
    -   id: MESH:D012640
        label: Disease
        name: Tonic-clonic seizure
    reference:
    - https://go.drugbank.com/drugs/DB00794
    - https://en.wikipedia.org/wiki/Primidone#Mechanism_of_action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL856/
-   comment: Primidone MoA is unknown. Its major metabolite are, phenobarbital and Phenylethylmalonamide,
             which are likely contributes to primidone's effects in many forms of epilepsy.
    directed: true
    graph:
        disease: Lennox-Gastaut syndrome
        disease_mesh: MESH:D065768
        drug: primidone
        drug_mesh: MESH:D011324
        drugbank: DB:DB00794
    links:
    -   key: has metabolite
        source: MESH:D011324
        target: CHEBI:8069
    -   key: has metabolite
        source: MESH:D011324
        target: CHEBI:8097
    -   key: increases activity of
        source: CHEBI:8069
        target: InterPro:IPR006028
    -   key: increases activity of
        source: CHEBI:8097
        target: InterPro:IPR006028
    -   key: positively regulates
        source: InterPro:IPR006028
        target: GO:0022851
    -   key: participates in
        source: InterPro:IPR006028
        target: GO:0022851
    -   key: positively correlated with
        source: GO:0022851
        target: GO:0060081
    -   key: negatively regulates
        source: GO:0060081
        target: GO:0019228
    -   key: contributes to
        source: GO:0019228
        target: GO:0050806
    -   key: positively correlated with
        source: GO:0050806
        target: MESH:D065768
    multigraph: true
    nodes:
    -   id: MESH:D011324
        label: Drug
        name: primidone
    -   id: CHEBI:8069
        label: ChemicalSubstance
        name: phenobarbital
    -   id: CHEBI:8097
        label: ChemicalSubstance
        name: Phenylethylmalonamide
    -   id: InterPro:IPR006028
        label: GeneFamily
        name: Gamma-aminobutyric acid A receptor/Glycine receptor alpha
    -   id: GO:0022851
        label: MolecularActivity
        name: GABA-gated chloride ion channel activity
    -   id: GO:0060081
        label: BiologicalProcess
        name: membrane hyperpolarization
    -   id: GO:0019228
        label: BiologicalProcess
        name: neuronal action potential
    -   id: GO:0050806
        label: BiologicalProcess
        name: positive regulation of synaptic transmission
    -   id: MESH:D065768
        label: Disease
        name: Lennox-Gastaut syndrome
    reference:
    - https://go.drugbank.com/drugs/DB00794
    - https://en.wikipedia.org/wiki/Primidone#Mechanism_of_action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL856/
-   comment: Primidone MoA is unknown. Its major metabolite are, phenobarbital and Phenylethylmalonamide,
             which are likely contributes to primidone's effects in many forms of epilepsy.
    directed: true
    graph:
        disease: Tonic-clonic epilepsy
        disease_mesh: MESH:D004830
        drug: primidone
        drug_mesh: MESH:D011324
        drugbank: DB:DB00794
    links:
    -   key: has metabolite
        source: MESH:D011324
        target: CHEBI:8069
    -   key: has metabolite
        source: MESH:D011324
        target: CHEBI:8097
    -   key: increases activity of
        source: CHEBI:8069
        target: InterPro:IPR006028
    -   key: increases activity of
        source: CHEBI:8097
        target: InterPro:IPR006028
    -   key: positively regulates
        source: InterPro:IPR006028
        target: GO:0022851
    -   key: participates in
        source: InterPro:IPR006028
        target: GO:0022851
    -   key: positively correlated with
        source: GO:0022851
        target: GO:0060081
    -   key: negatively regulates
        source: GO:0060081
        target: GO:0019228
    -   key: contributes to
        source: GO:0019228
        target: GO:0050806
    -   key: positively correlated with
        source: GO:0050806
        target: MESH:D004830
    multigraph: true
    nodes:
    -   id: MESH:D011324
        label: Drug
        name: primidone
    -   id: CHEBI:8069
        label: ChemicalSubstance
        name: phenobarbital
    -   id: CHEBI:8097
        label: ChemicalSubstance
        name: Phenylethylmalonamide
    -   id: InterPro:IPR006028
        label: GeneFamily
        name: Gamma-aminobutyric acid A receptor/Glycine receptor alpha
    -   id: GO:0022851
        label: MolecularActivity
        name: GABA-gated chloride ion channel activity
    -   id: GO:0060081
        label: BiologicalProcess
        name: membrane hyperpolarization
    -   id: GO:0019228
        label: BiologicalProcess
        name: neuronal action potential
    -   id: GO:0050806
        label: BiologicalProcess
        name: positive regulation of synaptic transmission
    -   id: MESH:D004830
        label: Disease
        name: Tonic-clonic epilepsy
    reference:
    - https://go.drugbank.com/drugs/DB00794
    - https://en.wikipedia.org/wiki/Primidone#Mechanism_of_action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL856/
-   directed: true
    graph:
        disease: Thrombosis
        disease_mesh: MESH:D013927
        drug: phenprocoumon
        drug_mesh: MESH:D010644
        drugbank: DB:DB00946
    links:
    -   key: decreases activity of
        source: MESH:D010644
        target: UniProt:Q9BQB6
    -   key: participates in
        source: UniProt:Q9BQB6
        target: GO:0042373
    -   key: produces
        source: GO:0042373
        target: MESH:D014812
    -   key: positively correlated with
        source: MESH:D014812
        target: GO:0072378
    -   key: positively correlated with
        source: GO:0072378
        target: UBERON:0010210
    -   key: affects risk for
        source: UBERON:0010210
        target: MESH:D013927
    multigraph: true
    nodes:
    -   id: MESH:D010644
        label: Drug
        name: phenprocoumon
    -   id: UniProt:Q9BQB6
        label: Protein
        name: Vitamin K epoxide reductase complex subunit 1
    -   id: GO:0042373
        label: BiologicalProcess
        name: Vitamin K metabolic process
    -   id: MESH:D014812
        label: ChemicalSubstance
        name: vitamin k
    -   id: GO:0072378
        label: BiologicalProcess
        name: blood coagulation, fibrin clot formation
    -   id: UBERON:0010210
        label: GrossAnatomicalStructure
        name: Blood clot
    -   id: MESH:D013927
        label: Disease
        name: Thrombosis
    reference:
    - https://go.drugbank.com/drugs/DB00946
    - https://en.wikipedia.org/wiki/Phenprocoumon
-   directed: true
    graph:
        disease: Myocardial infarction
        disease_mesh: MESH:D009203
        drug: phenprocoumon
        drug_mesh: MESH:D010644
        drugbank: DB:DB00946
    links:
    -   key: decreases activity of
        source: MESH:D010644
        target: UniProt:Q9BQB6
    -   key: participates in
        source: UniProt:Q9BQB6
        target: GO:0042373
    -   key: produces
        source: GO:0042373
        target: MESH:D014812
    -   key: positively correlated with
        source: MESH:D014812
        target: GO:0072378
    -   key: positively correlated with
        source: GO:0072378
        target: UBERON:0010210
    -   key: affects risk for
        source: UBERON:0010210
        target: MESH:D009203
    multigraph: true
    nodes:
    -   id: MESH:D010644
        label: Drug
        name: phenprocoumon
    -   id: UniProt:Q9BQB6
        label: Protein
        name: Vitamin K epoxide reductase complex subunit 1
    -   id: GO:0042373
        label: BiologicalProcess
        name: Vitamin K metabolic process
    -   id: MESH:D014812
        label: ChemicalSubstance
        name: vitamin k
    -   id: GO:0072378
        label: BiologicalProcess
        name: blood coagulation, fibrin clot formation
    -   id: UBERON:0010210
        label: GrossAnatomicalStructure
        name: Blood clot
    -   id: MESH:D009203
        label: Disease
        name: Myocardial infarction
    reference:
    - https://go.drugbank.com/drugs/DB00946
    - https://en.wikipedia.org/wiki/Phenprocoumon
-   directed: true
    graph:
        disease: Thromboembolic disorder
        disease_mesh: MESH:D013923
        drug: phenprocoumon
        drug_mesh: MESH:D010644
        drugbank: DB:DB00946
    links:
    -   key: decreases activity of
        source: MESH:D010644
        target: UniProt:Q9BQB6
    -   key: participates in
        source: UniProt:Q9BQB6
        target: GO:0042373
    -   key: produces
        source: GO:0042373
        target: MESH:D014812
    -   key: positively correlated with
        source: MESH:D014812
        target: GO:0072378
    -   key: positively correlated with
        source: GO:0072378
        target: UBERON:0010210
    -   key: affects risk for
        source: UBERON:0010210
        target: MESH:D013923
    multigraph: true
    nodes:
    -   id: MESH:D010644
        label: Drug
        name: phenprocoumon
    -   id: UniProt:Q9BQB6
        label: Protein
        name: Vitamin K epoxide reductase complex subunit 1
    -   id: GO:0042373
        label: BiologicalProcess
        name: Vitamin K metabolic process
    -   id: MESH:D014812
        label: ChemicalSubstance
        name: vitamin k
    -   id: GO:0072378
        label: BiologicalProcess
        name: blood coagulation, fibrin clot formation
    -   id: UBERON:0010210
        label: GrossAnatomicalStructure
        name: Blood clot
    -   id: MESH:D013923
        label: Disease
        name: Thromboembolic disorder
    reference:
    - https://go.drugbank.com/drugs/DB00946
    - https://en.wikipedia.org/wiki/Phenprocoumon
-   comment: Topical doxepin is approved for short-term (up to 8 days) management of moderate pruritus in adult patients
             with atopic dermatitis, pruritus or lichen simplex chronicus. Antihistamine properties of doxepin is beleived to be MoA
    directed: true
    graph:
        disease: Atopic dermatitis
        disease_mesh: MESH:D003876
        drug: doxepin
        drug_mesh: MESH:D004316
        drugbank: DB:DB01142
    links:
    -   key: decreases activity of
        source: MESH:D004316
        target: UniProt:P35367
    -   key: decreases activity of
        source: MESH:D004316
        target: UniProt:P25021
    -   key: positively regulates
        source: UniProt:P35367
        target: GO:0004969
    -   key: positively regulates
        source: UniProt:P25021
        target: GO:0004969
    -   key: participates in
        source: GO:0004969
        target: GO:0071420
    -   key: positively correlated with
        source: GO:0071420
        target: GO:0006954
    -   key: positively correlated with
        source: GO:0006954
        target: HP:0000989
    -   key: manifestation of
        source: HP:0000989
        target: MESH:D003876
    multigraph: true
    nodes:
    -   id: MESH:D004316
        label: Drug
        name: doxepin
    -   id: UniProt:P35367
        label: Protein
        name: Histamine H1 receptor
    -   id: UniProt:P25021
        label: Protein
        name: Histamine H2 receptor
    -   id: GO:0004969
        label: MolecularActivity
        name: Histamine receptor activity
    -   id: GO:0071420
        label: BiologicalProcess
        name: Cellular response to histamine
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: HP:0000989
        label: PhenotypicFeature
        name: Pruritus
    -   id: MESH:D003876
        label: Disease
        name: Atopic dermatitis
    reference:
    - https://go.drugbank.com/drugs/DB01142
    - https://en.wikipedia.org/wiki/Doxepin
    - https://pubmed.ncbi.nlm.nih.gov/9161661/
    - https://pubmed.ncbi.nlm.nih.gov/8089287/
-   comment: Topical doxepin is approved for short-term (up to 8 days) management of moderate pruritus in adult patients
             with atopic dermatitis, pruritus or lichen simplex chronicus. Antihistamine properties of doxepin is beleived to be MoA
    directed: true
    graph:
        disease: Itching of skin
        disease_mesh: MESH:D011537
        drug: doxepin
        drug_mesh: MESH:D004316
        drugbank: DB:DB01142
    links:
    -   key: decreases activity of
        source: MESH:D004316
        target: UniProt:P35367
    -   key: decreases activity of
        source: MESH:D004316
        target: UniProt:P25021
    -   key: positively regulates
        source: UniProt:P35367
        target: GO:0004969
    -   key: positively regulates
        source: UniProt:P25021
        target: GO:0004969
    -   key: participates in
        source: GO:0004969
        target: GO:0071420
    -   key: positively correlated with
        source: GO:0071420
        target: GO:0006954
    -   key: positively correlated with
        source: GO:0006954
        target: HP:0000989
    -   key: manifestation of
        source: HP:0000989
        target: MESH:D011537
    multigraph: true
    nodes:
    -   id: MESH:D004316
        label: Drug
        name: doxepin
    -   id: UniProt:P35367
        label: Protein
        name: Histamine H1 receptor
    -   id: UniProt:P25021
        label: Protein
        name: Histamine H2 receptor
    -   id: GO:0004969
        label: MolecularActivity
        name: Histamine receptor activity
    -   id: GO:0071420
        label: BiologicalProcess
        name: Cellular response to histamine
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: HP:0000989
        label: PhenotypicFeature
        name: Pruritus
    -   id: MESH:D011537
        label: Disease
        name: Itching of skin
    reference:
    - https://go.drugbank.com/drugs/DB01142
    - https://en.wikipedia.org/wiki/Doxepin
    - https://pubmed.ncbi.nlm.nih.gov/9161661/
    - https://pubmed.ncbi.nlm.nih.gov/8089287/
-   comment: Topical doxepin is approved for short-term (up to 8 days) management of moderate pruritus in adult patients
             with atopic dermatitis, pruritus or lichen simplex chronicus. Antihistamine properties of doxepin is beleived to be MoA
    directed: true
    graph:
        disease: Lichen simplex chronicus
        disease_mesh: MESH:D009450
        drug: doxepin
        drug_mesh: MESH:D004316
        drugbank: DB:DB01142
    links:
    -   key: decreases activity of
        source: MESH:D004316
        target: UniProt:P35367
    -   key: decreases activity of
        source: MESH:D004316
        target: UniProt:P25021
    -   key: positively regulates
        source: UniProt:P35367
        target: GO:0004969
    -   key: positively regulates
        source: UniProt:P25021
        target: GO:0004969
    -   key: participates in
        source: GO:0004969
        target: GO:0071420
    -   key: positively correlated with
        source: GO:0071420
        target: GO:0006954
    -   key: positively correlated with
        source: GO:0006954
        target: HP:0000989
    -   key: manifestation of
        source: HP:0000989
        target: MESH:D009450
    multigraph: true
    nodes:
    -   id: MESH:D004316
        label: Drug
        name: doxepin
    -   id: UniProt:P35367
        label: Protein
        name: Histamine H1 receptor
    -   id: UniProt:P25021
        label: Protein
        name: Histamine H2 receptor
    -   id: GO:0004969
        label: MolecularActivity
        name: Histamine receptor activity
    -   id: GO:0071420
        label: BiologicalProcess
        name: Cellular response to histamine
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: HP:0000989
        label: PhenotypicFeature
        name: Pruritus
    -   id: MESH:D009450
        label: Disease
        name: Lichen simplex chronicus
    reference:
    - https://go.drugbank.com/drugs/DB01142
    - https://en.wikipedia.org/wiki/Doxepin
    - https://pubmed.ncbi.nlm.nih.gov/9161661/
    - https://pubmed.ncbi.nlm.nih.gov/8089287/
-   comment: Oral doxepin is approved for the depression and/or anxiety, psychotic depressive disorders with associated anxiety
             and insomnia. The inhibition of norepinephrine and serotonin at synaptic nerve terminals by doxepin is beleived to be MoA
    directed: true
    graph:
        disease: Depressive disorder
        disease_mesh: MESH:D003866
        drug: doxepin
        drug_mesh: MESH:D004316
        drugbank: DB:DB01142
    links:
    -   key: decreases activity of
        source: MESH:D004316
        target: UniProt:P31645
    -   key: decreases activity of
        source: MESH:D004316
        target: UniProt:P23975
    -   key: participates in
        source: UniProt:P31645
        target: GO:0051610
    -   key: participates in
        source: UniProt:P23975
        target: GO:0051620
    -   key: decreases abundance of
        source: GO:0051620
        target: MESH:D009638
    -   key: decreases abundance of
        source: GO:0051610
        target: MESH:D012701
    -   key: positively correlated with
        source: MESH:D012701
        target: GO:0060096
    -   key: positively correlated with
        source: MESH:D009638
        target: GO:0061533
    -   key: negatively regulates
        source: GO:0060096
        target: MESH:D003866
    -   key: negatively regulates
        source: GO:0061533
        target: MESH:D003866
    multigraph: true
    nodes:
    -   id: MESH:D004316
        label: Drug
        name: doxepin
    -   id: UniProt:P31645
        label: Protein
        name: Sodium-dependent serotonin transporter
    -   id: UniProt:P23975
        label: Protein
        name: Sodium-dependent noradrenaline transporter
    -   id: GO:0051610
        label: BiologicalProcess
        name: Serotonin uptake
    -   id: MESH:D012701
        label: ChemicalSubstance
        name: Serotonin
    -   id: GO:0051620
        label: BiologicalProcess
        name: Noradrenaline uptake
    -   id: MESH:D009638
        label: ChemicalSubstance
        name: Noradrenaline
    -   id: GO:0061533
        label: BiologicalProcess
        name: Norepinephrine secretion, neurotransmission
    -   id: GO:0060096
        label: BiologicalProcess
        name: Serotonin secretion, neurotransmission
    -   id: MESH:D003866
        label: Disease
        name: Depressive disorder
    reference:
    - https://go.drugbank.com/drugs/DB01142
    - https://en.wikipedia.org/wiki/Doxepin
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1628227/
-   comment: Oral doxepin is approved for the depression and/or anxiety, psychotic depressive disorders with associated anxiety
             and insomnia. The inhibition of norepinephrine and serotonin at synaptic nerve terminals by doxepin is beleived to be MoA
    directed: true
    graph:
        disease: Anxiety
        disease_mesh: MESH:D001007
        drug: doxepin
        drug_mesh: MESH:D004316
        drugbank: DB:DB01142
    links:
    -   key: decreases activity of
        source: MESH:D004316
        target: UniProt:P31645
    -   key: decreases activity of
        source: MESH:D004316
        target: UniProt:P23975
    -   key: participates in
        source: UniProt:P31645
        target: GO:0051610
    -   key: participates in
        source: UniProt:P23975
        target: GO:0051620
    -   key: decreases abundance of
        source: GO:0051620
        target: MESH:D009638
    -   key: decreases abundance of
        source: GO:0051610
        target: MESH:D012701
    -   key: positively correlated with
        source: MESH:D012701
        target: GO:0060096
    -   key: positively correlated with
        source: MESH:D009638
        target: GO:0061533
    -   key: negatively regulates
        source: GO:0060096
        target: MESH:D001007
    -   key: negatively regulates
        source: GO:0061533
        target: MESH:D001007
    multigraph: true
    nodes:
    -   id: MESH:D004316
        label: Drug
        name: doxepin
    -   id: UniProt:P31645
        label: Protein
        name: Sodium-dependent serotonin transporter
    -   id: UniProt:P23975
        label: Protein
        name: Sodium-dependent noradrenaline transporter
    -   id: GO:0051610
        label: BiologicalProcess
        name: Serotonin uptake
    -   id: MESH:D012701
        label: ChemicalSubstance
        name: Serotonin
    -   id: GO:0051620
        label: BiologicalProcess
        name: Noradrenaline uptake
    -   id: MESH:D009638
        label: ChemicalSubstance
        name: Noradrenaline
    -   id: GO:0061533
        label: BiologicalProcess
        name: Norepinephrine secretion, neurotransmission
    -   id: GO:0060096
        label: BiologicalProcess
        name: Serotonin secretion, neurotransmission
    -   id: MESH:D001007
        label: Disease
        name: Anxiety
    reference:
    - https://go.drugbank.com/drugs/DB01142
    - https://en.wikipedia.org/wiki/Doxepin
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1628227/
-   comment: Oral doxepin is approved for the depression and/or anxiety, psychotic depressive disorders with associated anxiety
             and insomnia. The inhibition of norepinephrine and serotonin at synaptic nerve terminals by doxepin is beleived to be MoA
    directed: true
    graph:
        disease: Bipolar affective disorder, current episode depression
        disease_mesh: MESH:D001714
        drug: doxepin
        drug_mesh: MESH:D004316
        drugbank: DB:DB01142
    links:
    -   key: decreases activity of
        source: MESH:D004316
        target: UniProt:P31645
    -   key: decreases activity of
        source: MESH:D004316
        target: UniProt:P23975
    -   key: participates in
        source: UniProt:P31645
        target: GO:0051610
    -   key: participates in
        source: UniProt:P23975
        target: GO:0051620
    -   key: decreases abundance of
        source: GO:0051620
        target: MESH:D009638
    -   key: decreases abundance of
        source: GO:0051610
        target: MESH:D012701
    -   key: positively correlated with
        source: MESH:D012701
        target: GO:0060096
    -   key: positively correlated with
        source: MESH:D009638
        target: GO:0061533
    -   key: negatively regulates
        source: GO:0060096
        target: MESH:D001714
    -   key: negatively regulates
        source: GO:0061533
        target: MESH:D001714
    multigraph: true
    nodes:
    -   id: MESH:D004316
        label: Drug
        name: doxepin
    -   id: UniProt:P31645
        label: Protein
        name: Sodium-dependent serotonin transporter
    -   id: UniProt:P23975
        label: Protein
        name: Sodium-dependent noradrenaline transporter
    -   id: GO:0051610
        label: BiologicalProcess
        name: Serotonin uptake
    -   id: MESH:D012701
        label: ChemicalSubstance
        name: Serotonin
    -   id: GO:0051620
        label: BiologicalProcess
        name: Noradrenaline uptake
    -   id: MESH:D009638
        label: ChemicalSubstance
        name: Noradrenaline
    -   id: GO:0061533
        label: BiologicalProcess
        name: Norepinephrine secretion, neurotransmission
    -   id: GO:0060096
        label: BiologicalProcess
        name: Serotonin secretion, neurotransmission
    -   id: MESH:D001714
        label: Disease
        name: Bipolar affective disorder, current episode depression
    reference:
    - https://go.drugbank.com/drugs/DB01142
    - https://en.wikipedia.org/wiki/Doxepin
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1628227/
-   directed: true
    graph:
        disease: Acromegaly
        disease_mesh: MESH:D000172
        drug: lanreotide
        drug_mesh: MESH:C060347
        drugbank: DB:DB06791
    links:
    -   key: chemically similar to
        source: MESH:C060347
        target: MESH:D013004
    -   key: increases activity of
        source: MESH:D013004
        target: UniProt:P30874
    -   key: increases activity of
        source: MESH:D013004
        target: UniProt:P35346
    -   key: participates in
        source: UniProt:P30874
        target: GO:0038169
    -   key: participates in
        source: UniProt:P35346
        target: GO:0038169
    -   key: negatively regulates
        source: GO:0038169
        target: MESH:D000172
    multigraph: true
    nodes:
    -   id: MESH:C060347
        label: Drug
        name: lanreotide
    -   id: MESH:D013004
        label: ChemicalSubstance
        name: Somatostatin
    -   id: UniProt:P30874
        label: Protein
        name: Somatostatin receptor type 2
    -   id: UniProt:P35346
        label: Protein
        name: Somatostatin receptor type 5
    -   id: GO:0038169
        label: BiologicalProcess
        name: Somatostatin receptor signaling pathway
    -   id: MESH:D000172
        label: Disease
        name: Acromegaly
    reference:
    - https://go.drugbank.com/drugs/DB06791
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201185/
    - https://en.wikipedia.org/wiki/Lanreotide
-   directed: true
    graph:
        disease: Pulmonary arterial hypertension
        disease_mesh: MESH:D000081029
        drug: riociguat
        drug_mesh: MESH:C542595
        drugbank: DB:DB08931
    links:
    -   key: increases activity of
        source: MESH:C542595
        target: UniProt:P33402
    -   key: increases abundance of
        source: UniProt:P33402
        target: CHEBI:16356
    -   key: participates in
        source: CHEBI:16356
        target: GO:0038060
    -   key: contributes to
        source: GO:0038060
        target: GO:0042311
    -   key: contributes to
        source: GO:0042311
        target: GO:0060087
    -   key: prevents
        source: GO:0060087
        target: MESH:D000081029
    multigraph: true
    nodes:
    -   id: MESH:C542595
        label: Drug
        name: riociguat
    -   id: UniProt:P33402
        label: Protein
        name: Guanylate cyclase soluble subunit alpha-2
    -   id: CHEBI:16356
        label: ChemicalSubstance
        name: cyclic guanosine 3',5' monophosphate
    -   id: GO:0038060
        label: BiologicalProcess
        name: nitric oxide-cGMP-mediated signaling pathway
    -   id: GO:0042311
        label: BiologicalProcess
        name: vasodilation
    -   id: GO:0060087
        label: BiologicalProcess
        name: vasular smooth muscle relaxation
    -   id: MESH:D000081029
        label: Disease
        name: Pulmonary arterial hypertension
    reference:
    - https://go.drugbank.com/drugs/DB08931
    - https://pubmed.ncbi.nlm.nih.gov/27263466/
    - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218670/
    - https://pubmed.ncbi.nlm.nih.gov/19263460/
-   directed: true
    graph:
        disease: von Willebrand disorder
        disease_mesh: MESH:D014842
        drug: vonicog alfa
        drug_mesh: MESH:D014841
        drugbank: DB:DB12872
    links:
    -   key: chemically similar to
        source: MESH:D014841
        target: UniProt:P04275
    -   key: increases stability of
        source: UniProt:P04275
        target: UniProt:P00451
    -   key: positively regulates
        source: UniProt:P00451
        target: GO:0007596
    -   key: increases activity of
        source: MESH:D014841
        target: UniProt:P02452
    -   key: located in
        source: UniProt:P02452
        target: UBERON:0035965
    -   key: location of
        source: UBERON:0035965
        target: GO:0007596
    -   key: negatively correlated with
        source: GO:0007596
        target: MESH:D014842
    multigraph: true
    nodes:
    -   id: MESH:D014841
        label: Drug
        name: vonicog alfa
    -   id: UniProt:P04275
        label: Protein
        name: von Willebrand factor
    -   id: UniProt:P00451
        label: Protein
        name: Coagulation factor VIII
    -   id: UniProt:P02452
        label: Protein
        name: Collagen alpha-1(I) chain
    -   id: UBERON:0035965
        label: GrossAnatomicalStructure
        name: wall of blood vessel
    -   id: GO:0007596
        label: BiologicalProcess
        name: Blood coagulation
    -   id: MESH:D014842
        label: Disease
        name: Von Willebrand disorder
    reference:
    - https://go.drugbank.com/drugs/DB12872
